COVID-19: Mayo Clinic is committed to taking care of our patients, learners and staff. Learn more about attendance requirements for live courses and conferences and available COVID-19 online education and resources.
Genentech - Exhibitor

Contact Information:

Greg Voisin- Arizona
Therapeutic Area Manager, Lung-Genentech USA, Inc.
Phone: 949-680-5364

Dave Marcou- Arizona
Therapeutic Area Manager, Lung-Genentech USA, Inc.
Phone: 602-513-1431

Randy Miller-Minnesota
Therapeutic Area Manager-Lung
Phone: 952-807-3235

Heather Cochran-Florida
Therapeutic Area Manager-Lung
Phone: 407-446-7844

Virtual Meeting Link

Available during all breaks and pre-conference times as indicated on Representatives will be available during scheduled breaks, the lunch hour, and at the end of each day.

*If you need information during non-break times, please text Greg Voisin: 949-680-5364 or Dave Marcou: 602-513-1431


Virtual Exhibit Hall Home


Considered the founder of the industry, Genentech, now a member of the Roche Group, has been delivering on the promise of biotechnology for more than 40 years.
Genentech is a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases. Our transformational discoveries include the first targeted antibody for cancer and the first medicine for primary progressive multiple sclerosis.

A Member of the Roche Group, Genentech became a member of the Roche Group in March of 2009. As part of their merger agreement, Roche and Genentech combined their pharmaceutical operations in the United States. Genentech's South San Francisco campus now serves as the headquarters for Roche pharmaceutical operations in the United States. Genentech Research and Early Development operates as an independent center within Roche.

Tecentriq HCC Information

Tecentriq Patient Care Guide

Tecentriq Prescribing Information